Eyedea Medical awarded aggressive Nationwide Science Basis Section II Small Enterprise Innovation Analysis Grant, Baltimore, MD
BALTIMORE, Feb. 23, 2023 /PRNewswire/ — Eyedea Medical, a Baltimore-based medtech startup working to alleviate the burden of corneal blindness via revolutionary options in corneal transplantation and eye banking, has been awarded a $1,000,000 Section II Small Enterprise Innovation Analysis (SBIR) grant from the Nationwide Science Basis (NSF). The grant will present further help for the event and commercialization of its proprietary corneal tissue preparation gadgets, DescePrep™ and DesceCleave™. These novel gadgets enable for easy, environment friendly, and standardized separation of layers of the cornea so as to enhance entry to and adoption of vision-restoring corneal transplant methods, together with Descemet’s Membrane Endothelial Keratoplasty (DMEK) and Deep Anterior Lamellar Keratoplasty (DALK).
Corneal blindness is devastating for sufferers, their households, and communities globally. Collectively, DescePrep and DesceCleave tackle key limitations for elevated adoption of corneal transplant methods that may deal with 90% of people ready for a corneal transplant. Offering higher instruments for DMEK and DALK will enhance entry to corneal transplant procedures and allow extra sufferers to regain independence and productiveness.
“As much as 30 million people are ready for a corneal transplant regardless of corneal blindness being preventable or treatable in 95% of instances. Our crew believes entry to imaginative and prescient care is a human proper, and we based Eyedea Medical to create applied sciences to assist get rid of avoidable blindness. The Section II award validates our core expertise platform and its potential to have a tangible influence on eye care,” stated Katie Solley, co-founder and CEO of Eyedea Medical.
The Section II award builds off of a earlier $225,000 NSF Section I grant to de-risk the event of Eyedea Medical’s first product, DescePrep™. The Section II award goals to additional validate DescePrep™ to be used by eye banks and to adapt the core expertise to an extra utility in DALK surgical procedure, with potential for broad international influence.
About Eyedea Medical, Inc
Eyedea Medical is a Baltimore-based, lady led, early stage medtech firm constructing a pipeline of merchandise to extend entry and adoption of vision-restoring corneal transplant procedures. Eyedea Medical was based by a bunch of biomedical engineers and ophthalmologists to leverage each technological and enterprise mannequin improvements to make sure that everybody has entry to the very best eye care whatever the circumstances of their beginning. For extra data, please go to: https://www.eyedeamedical.com/
In regards to the Nationwide Science Basis’s Small Enterprise Applications
America’s Seed Fund powered by NSF awards $200 million yearly to startups and small companies, remodeling scientific discovery into services with business and societal influence. Startups working throughout virtually all areas of science and expertise can obtain as much as $2 million to help analysis and improvement (R&D), serving to de-risk expertise for business success. America’s Seed Fund is congressionally mandated via the Small Enterprise Innovation Analysis (SBIR) program. The NSF is an impartial federal company with a price range of about $8.5 billion that helps basic analysis and training throughout all fields of science and engineering.
View unique content material:https://www.prnewswire.com/news-releases/eyedea-medical-awarded-competitive-national-science-foundation-phase-ii-small-business-innovation-research-grant-baltimore-md-301753563.html
SOURCE Eyedea Medical, Inc
